"use strict";(self.webpackChunkBenStockTracker=self.webpackChunkBenStockTracker||[]).push([[676],{5676:e=>{e.exports=JSON.parse('{"c150cca1-c723-3b99-9f3c-1e8f622a440b":{"uuid":"c150cca1-c723-3b99-9f3c-1e8f622a440b","title":"Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover","publisher":"Morningstar Research","link":"https://finance.yahoo.com/m/c150cca1-c723-3b99-9f3c-1e8f622a440b/morningstar-%7C-a-weekly.html","providerPublishTime":1653686107,"type":"STORY"},"a3abbe7b-6f9b-3e40-9cbb-1eee957b67c4":{"uuid":"a3abbe7b-6f9b-3e40-9cbb-1eee957b67c4","title":"Portugal\'s Positive Approach to Teaching Teens about the Birds, Bees and STIs","publisher":"News Direct","link":"https://finance.yahoo.com/news/portugals-positive-approach-teaching-teens-124608104.html","providerPublishTime":1653655568,"type":"STORY"},"c7a190f2-a003-3889-971c-cc17293af397":{"uuid":"c7a190f2-a003-3889-971c-cc17293af397","title":"Analyst Report: Gilead Sciences, Inc.","publisher":"Morningstar Research","link":"https://finance.yahoo.com/m/c7a190f2-a003-3889-971c-cc17293af397/analyst-report%3A-gilead.html","providerPublishTime":1653603335,"type":"STORY"},"71d9dd8c-8557-3055-a844-891a59adcb36":{"uuid":"71d9dd8c-8557-3055-a844-891a59adcb36","title":"Why NRX Pharmaceuticals Shares Are Trading Lower During Premarket On Thursday?","publisher":"Benzinga","link":"https://finance.yahoo.com/news/why-nrx-pharmaceuticals-shares-trading-114606785.html","providerPublishTime":1653565566,"type":"STORY"},"bb8009d0-7e4e-3a75-bb73-24829d2cb8a5":{"uuid":"bb8009d0-7e4e-3a75-bb73-24829d2cb8a5","title":"Peninsula biotech breaks off hepatitis B deal after partner\'s drug falters","publisher":"American City Business Journals","link":"https://finance.yahoo.com/m/bb8009d0-7e4e-3a75-bb73-24829d2cb8a5/peninsula-biotech-breaks-off.html","providerPublishTime":1653491162,"type":"STORY"},"a9fe34f6-8dce-31f3-ae61-a54a545fb61f":{"uuid":"a9fe34f6-8dce-31f3-ae61-a54a545fb61f","title":"Gilead Reaches Number One Spot as Top Overall Philanthropic Funder of HIV-Related Programs, According to Funders Concerned About AIDS Report","publisher":"News Direct","link":"https://finance.yahoo.com/news/gilead-reaches-number-one-spot-132606662.html","providerPublishTime":1653485166,"type":"STORY"},"871b1096-f3eb-3a88-a0fb-534e06c76980":{"uuid":"871b1096-f3eb-3a88-a0fb-534e06c76980","title":"The Zacks Analyst Blog Highlights JPMorgan Chase, Gilead Sciences, CSX, CVS Health and China Petroleum & Chemical","publisher":"Zacks","link":"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-jpmorgan-102210060.html","providerPublishTime":1653301330,"type":"STORY"},"19835d26-01ca-3da4-b6fd-eecbf488dc05":{"uuid":"19835d26-01ca-3da4-b6fd-eecbf488dc05","title":"Top Research Reports for JPMorgan, Gilead Sciences & CSX","publisher":"Zacks","link":"https://finance.yahoo.com/news/top-research-reports-jpmorgan-gilead-170805049.html","providerPublishTime":1653066485,"type":"STORY"}}')}}]);